THE ETHICAL OBLIGATIONS OF PHARMACEUTICAL COMPANIES IN A GLOBAL HEALTH EMERGENCY – CASE STUDY: COVID-19 VACCINES
Dr. Ezekiel J. Emanuel, MD, PhD, Vice Provost for Global Initiatives, Diane v.S. Levy and Robert M. Levy University Professor and Co-Director, Healthcare Transformation Institute at the University of Pennsylvania […]
HIGHLY PREVALENT NEGLECTED DISEASES: DEVELOPING MEDICINES AND BUILDING INFRASTRUCTURE FOR THE REST OF THE WORLD
Background While COVID-19 highlighted the importance of health investments, particularly for innovative therapies to address high-impact global health challenges, the pandemic diverted attention and much-needed resources from other disease areas. […]
INCLUSIVE MEDICINE: HOW MODERN RESEARCH AMPLIFIES OUTCOMES FOR PATIENT ACCESS, INCLUSION AND DIVERSITY
Background There has never been more potential to create an industry centered around patient access, inclusion, and diversity than there is today. While traditional approaches have long been responsible for […]
PANEL 1
FIRESIDE DISCUSSION
PANEL 2
Forum 2021 Program
JEF 2021 Program JEF 2022JEF 2020JEF 2019 PANEL 1 INCLUSIVE MEDICINE: HOW MODERN RESEARCH AMPLIFIES OUTCOMES FOR PATIENT ACCESS, INCLUSION AND DIVERSITY Thursday, November 11th 8:30 am – 9:30 am […]
